If this email is not displaying properly, please go here .

Pennsylvania Hospital Becomes OUD Treatment Model After Working with PCSS During Pilot Program

Hanover Hospital and its affiliated healthcare clinics has become a model for how a healthcare system that is fully engaged in embracing evidence-based treatment of opioid use disorders can make significant change. 

A little more than a year ago, PCSS reached out to Hanover Hospital to participate in a five-state pilot program to create a medication assisted treatment (MAT) program. Since then, PCSS has worked closely with clinicians, administrators, and support staff to increase understanding of preventing, identifying, and treating OUD. [ Read more ]

PCSS Training . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Webinar Tomorrow: Treatment of Pain in the SUD Patients

Date: May 25, 2018

Time: 12:00 - 1:00 pm ET

Presenters: Allen Masry, MD

Sponsor: International Nurses Society on Addictions ( IntNSA)

Webinar description: This webinar will cover material on chronic and acute pain in the person with Substance Use Disorders. The differences between chronic... [ More ]

Adolescent Pain Management and NSAID Considerations

Date: June 7, 2018

Time: 11:00 am - 12:00 pm ET

Presenters: Paul A. Moore, DMD, PhD, MPH

Sponsor: American Dental Association ( ADA)

Webinar description: Safe and effective treatment of acute postoperative pain is essential for patient satisfaction and successful practice in dentistry. Because of the growing crisis from illicit and prescription opioid abuse, dentists... [ More ]

Of Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACEP and Yale Team Up to Create Opioid Toolkit for EDs

The Addiction Policy Forum has partnered with the Yale School of Medicine and the American College of Emergency Physicians (ACEP) to disseminate best practices and implement evidence-based interventions in the Emergency Department to reduce harm from opioids. The goal of toolkit is to empower patients, families, healthcare providers and policymakers to work collaboratively to identify patients in need of help, initiate evidence-based treatments, and connect patients and families to comprehensive support services.  [ Read more ]

FDA approves first medication to reduce opioid withdrawal symptoms

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that lofexidine, the first medication for use in reducing symptoms associated with opioid withdrawal in adults, has been approved by the U.S. Food and Drug Administration.  [ Read more ]

News and Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

National Institutes of Health

NIH study explains why opioid therapy may not always work well for chronic pain

Medscape

The Anals of Internal Medicine

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study

Drug and Alcohol Dependence

Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States

NIDA News

FDA approves first medication to reduce opioid withdrawal symptoms

Study upends conventional view of opioid mechanism of action

Obstetrics & Gynecology

Opioid Detoxification During Pregnancy: A Systematic Review

Chicago Tribune

Opioid epidemic to cost state $4 billion this year, Indiana University study finds

PCSS Online Brochure. Please share this link with colleagues: https://goo.gl/G1ay6H

Funding for this initiative was made possible (in part) by grant nos. 5H79TI025595-03, 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.